Erin Walsh1, Tory Eisenlohr-Moul2, Ruth Baer3. 1. Department of Physical Medicine and Rehabilitation. 2. Department of Psychiatry, University of North Carolina at Chapel Hill. 3. Department of Psychology, University of Kentucky.
Abstract
OBJECTIVE: Pro-inflammatory cytokines have been implicated in the pathophysiology and maintenance of depression. This study investigated the effects of a brief mindfulness intervention on salivary pro-inflammatory correlates of depression (IL-6, TNF-α) and self-reported symptoms of depression in college women. METHODS: Sixty-four females with a cut score of ≥16 on the Center for Epidemiological Studies for Depression Scale (CES-D) were assigned to a 4-week mindfulness-based intervention (MBI; N = 31) or a contact-control group (N = 33). For both groups, salivary cytokines and depressive symptoms were assessed at baseline and posttreatment. For the mindfulness group only, salivary cytokines were also assessed at a 3-month follow-up. RESULTS: Both groups showed similar reductions in depression. However, MBI (vs. control) predicted greater reductions in IL-6 and TNF-α; changes in IL-6 were sustained at 3-month follow-up. Higher baseline depressive symptoms predicted greater reductions in inflammation in the mindfulness group. CONCLUSION: MBIs may reduce inflammatory immune markers commonly implicated in depression. Individuals with greater depressive symptoms may benefit more from mindfulness training. Although reductions in salivary cytokines in the mindfulness condition were not attributable to changes in depressive symptoms, future work should examine the possibility that such reductions are protective against the development of future depressive episodes. (PsycINFO Database Record (c) 2016 APA, all rights reserved).
OBJECTIVE: Pro-inflammatory cytokines have been implicated in the pathophysiology and maintenance of depression. This study investigated the effects of a brief mindfulness intervention on salivary pro-inflammatory correlates of depression (IL-6, TNF-α) and self-reported symptoms of depression in college women. METHODS: Sixty-four females with a cut score of ≥16 on the Center for Epidemiological Studies for Depression Scale (CES-D) were assigned to a 4-week mindfulness-based intervention (MBI; N = 31) or a contact-control group (N = 33). For both groups, salivary cytokines and depressive symptoms were assessed at baseline and posttreatment. For the mindfulness group only, salivary cytokines were also assessed at a 3-month follow-up. RESULTS: Both groups showed similar reductions in depression. However, MBI (vs. control) predicted greater reductions in IL-6 and TNF-α; changes in IL-6 were sustained at 3-month follow-up. Higher baseline depressive symptoms predicted greater reductions in inflammation in the mindfulness group. CONCLUSION: MBIs may reduce inflammatory immune markers commonly implicated in depression. Individuals with greater depressive symptoms may benefit more from mindfulness training. Although reductions in salivary cytokines in the mindfulness condition were not attributable to changes in depressive symptoms, future work should examine the possibility that such reductions are protective against the development of future depressive episodes. (PsycINFO Database Record (c) 2016 APA, all rights reserved).
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang Journal: JAMA Date: 2003-06-18 Impact factor: 56.272
Authors: Shufang Sun; Margaret A Sheridan; Audrey R Tyrka; Shannon D Donofry; Kirk I Erickson; Eric B Loucks Journal: Neurosci Biobehav Rev Date: 2022-01-05 Impact factor: 8.989
Authors: Yara J Toenders; Liliana Laskaris; Christopher G Davey; Michael Berk; Yuri Milaneschi; Femke Lamers; Brenda W J H Penninx; Lianne Schmaal Journal: Mol Psychiatry Date: 2021-10-11 Impact factor: 15.992
Authors: Nicole R DeTore; Lauren Luther; Wisteria Deng; Jordan Zimmerman; Logan Leathem; Anne S Burke; Maren B Nyer; Daphne J Holt Journal: Psychol Med Date: 2022-03-01 Impact factor: 10.592
Authors: Franziska Holtdirk; Anja Mehnert; Mario Weiss; Johannes Mayer; Björn Meyer; Peter Bröde; Maren Claus; Carsten Watzl Journal: PLoS One Date: 2021-05-07 Impact factor: 3.240
Authors: George M Slavich; Matteo Giletta; Sarah W Helms; Paul D Hastings; Karen D Rudolph; Matthew K Nock; Mitchell J Prinstein Journal: Depress Anxiety Date: 2020-02 Impact factor: 8.128
Authors: Leina S Alrabadi; Anne Dutton; Anahita Rabiee; Scott J Roberts; Yanhong Deng; Laura Cusack; Marina G Silveira; Maria Ciarleglio; Richard Bucala; Rajita Sinha; James L Boyer; David N Assis Journal: JHEP Rep Date: 2022-02-18
Authors: Xiao Wang; Kristina Sundquist; Karolina Palmér; Anna Hedelius; A A Memon; Jan Sundquist Journal: Int J Neuropsychopharmacol Date: 2018-06-01 Impact factor: 5.176
Authors: Lorinda Turner; Julieta Galante; Maris Vainre; Jan Stochl; Géraldine Dufour; Peter B Jones Journal: Sci Rep Date: 2020-04-02 Impact factor: 4.379